In this Health Affairs blog post, Dr. Chua highlights the fact that many orphan drugs approved to treat rare diseases are either currently being used to treat COVID-19 patients off-label and/or are currently in COVID-19 clinical trials. Because orphan drug policy facilitates high prices, Dr. Chua argues that this policy unintentionally could impede access to potentially life-saving treatments for COVID-19.
News & Publications
June 15, 2020
Mott Poll: Parents twice as likely to be concerned about ticks transmitting diseases than they are of mosquitoes
Just 1 in 3 parents use a bug repellent on their child that contains DEET, which is most effective in repelling mosquitoes, new national poll finds.
May 18, 2020
2 in 3 parents worry that their tween might be targeted by ads with inappropriate content, 3 in 4 concerned that apps could make kids overly focused on weight.